UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New insights into the molecular mechanism of interleukin-10-mediated immunosuppression

Journal of leukocyte biology, 2005-01, Vol.77 (1), p.3-15

Gruetz, G

2005

Volltextzugriff (PDF)

Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4+ memory T cells

Nature communications, 2019-05, Vol.10 (1), p.2263-2263, Article 2263

2019

Volltextzugriff (PDF)

Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia

Nature immunology, 2010-08, Vol.11 (8), p.717-724

2010

Volltextzugriff (PDF)

Individual immune cell and cytokine profiles determine platelet-rich plasma composition

Arthritis research & therapy, 2023-01, Vol.25 (1), p.6-14, Article 6

2023

Volltextzugriff (PDF)

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD

Journal of neuroinflammation, 2022-10, Vol.19 (1), p.1-239, Article 239

2022

Volltextzugriff (PDF)

Gravitational stress during parabolic flights reduces the number of circulating innate and adaptive leukocyte subsets in human blood

PloS one, 2018-11, Vol.13 (11), p.e0206272-e0206272

2018

Volltextzugriff (PDF)

Naturally occurring anti–IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans

Blood, 2004-01, Vol.103 (2), p.673-675

2004

Volltextzugriff (PDF)

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis

Neurology and therapy, 2024-12, Vol.13 (6), p.1607-1625

2024

Volltextzugriff (PDF)

Expression of Tolerance Associated Gene-1, a Mitochondrial Protein Inhibiting T Cell Activation, Can Be Used to Predict Response to Immune Modulating Therapies

The Journal of immunology (1950), 2009-09, Vol.183 (6), p.4077-4087

2009

Volltextzugriff (PDF)

Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples

Transplantation, 2009-07, Vol.88 (1), p.89-95

2009

Volltextzugriff (PDF)

Biology of interleukin-10

Cytokine & growth factor reviews, 2010-10, Vol.21 (5), p.331-344

2010

Volltextzugriff (PDF)

IL-10 protects monocytes and macrophages from complement-mediated lysis

Journal of leukocyte biology, 2009-07, Vol.86 (1), p.155-166

2009

Volltextzugriff (PDF)

Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization

The Journal of immunology (1950), 2003-05, Vol.170 (10), p.5260-5267

2003

Volltextzugriff (PDF)

The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells

The EMBO journal, 1998-08, Vol.17 (16), p.4594-4605

1998

Volltextzugriff (PDF)

Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?

Journal of leukocyte biology, 2004-05, Vol.75 (5), p.792-797

2004

Volltextzugriff (PDF)

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial

International journal of cancer, 2019-09, Vol.145 (6), p.1538-1546

2019

Volltextzugriff (PDF)

Erratum: Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia

Nature immunology, 2010-10, Vol.11 (10), p.969-969

2010

Volltextzugriff (PDF)

Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment

European journal of immunology, 2021-05, Vol.51 (5), p.1278-1281

2021

Volltextzugriff (PDF)

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

Oncotarget, 2017-10, Vol.8 (46), p.80156-80166

2017

Volltextzugriff (PDF)

The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development

Cancer research (Chicago, Ill.), 1999-04, Vol.59 (7 Suppl), p.1794s-1798s

1999

Volltextzugriff (PDF)

IL-10 interferes directly with TCR-induced IFN-γ but not IL-17 production in memory T cells

European journal of immunology, 2009-04, Vol.39 (4), p.1066-1077

2009

Volltextzugriff (PDF)

Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapy

European journal of immunology, 2004-02, Vol.34 (2), p.481-493

2004

Volltextzugriff (PDF)

TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 production

The Journal of immunology (1950), 2015-04, Vol.194 (7), p.3136-3146

2015

Volltextzugriff (PDF)

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

The EMBO journal, 1997-06, Vol.16 (11), p.3145-3157

1997

Volltextzugriff (PDF)

A Critical Control Element for Interleukin-4 Memory Expression in T Helper Lymphocytes

The Journal of biological chemistry, 2005-08, Vol.280 (31), p.28177-28185

2005

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(35)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Humans
(17)
Immunology
(17)
Animals
(14)
Mice
(9)
Biochemistry & Molecular Biology
(6)
Biological And Medical Sciences
(5)
Cell Biology
(5)
Cells, Cultured
(5)
Dna-Binding Proteins - Genetics
(5)
Interleukin-10 - Pharmacology
(5)
Adaptor Proteins, Signal Transducing
(4)
Female
(4)
Immunotherapy
(4)
Inflammation
(4)
Lim Domain Proteins
(4)
Male
(4)
Medical Sciences
(4)
Monocytes - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

New insights into the molecular mechanism of interleukin-10-mediated immunosuppression

Killer-like receptors and GPR56 progressive expression defines cytokine production of human CD4+ memory T cells

Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia

Individual immune cell and cytokine profiles determine platelet-rich plasma composition

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD

Gravitational stress during parabolic flights reduces the number of circulating innate and adaptive leukocyte subsets in human blood

Naturally occurring anti–IFN-γ autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis

Expression of Tolerance Associated Gene-1, a Mitochondrial Protein Inhibiting T Cell Activation, Can Be Used to Predict Response to Immune Modulating Therapies

Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples

Biology of interleukin-10

IL-10 protects monocytes and macrophages from complement-mediated lysis

Different modes of IL-10 and TGF-beta to inhibit cytokine-dependent IFN-gamma production: consequences for reversal of lipopolysaccharide desensitization

The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells

Preassociation of nonactivated STAT3 molecules demonstrated in living cells using bioluminescence resonance energy transfer: a new model of STAT activation?

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial

Erratum: Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia

Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development

IL-10 interferes directly with TCR-induced IFN-γ but not IL-17 production in memory T cells

Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapy

TCAIM decreases T cell priming capacity of dendritic cells by inhibiting TLR-induced Ca2+ influx and IL-2 production

The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins

A Critical Control Element for Interleukin-4 Memory Expression in T Helper Lymphocytes

Suchergebnisse filtern